B
Bausch + Lomb Corp D
D
BLCO
17.930
USD
-0.05
(-0.25%)
Market Open
Volume
7,552
EPS
1
Div Yield
-
P/E
-18
Market Cap
6,338,752,562
Title: Bausch + Lomb Corp
Sector: Healthcare
Industry: Medical Instruments & Supplies
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.